F-star appoints new CEO, COO, and VP of Development and Expands Operations in Cambridge, UK
F-star is a leader in the development of novel bispecific antibodies.
Our technology leverages decades of experience with traditional antibody technology, while overcoming the limitations in the development and manufacture of bispecific antibodies